期刊
INTERNATIONAL JOURNAL OF PHARMACEUTICS
卷 523, 期 2, 页码 454-475出版社
ELSEVIER
DOI: 10.1016/j.ijpharm.2016.10.061
关键词
Myocardial infarction; Cell therapy; Protein therapy; Hydrogel; Biomaterial; Tissue engineering
资金
- Asociacion de amigos de la Universidad de Navarra
- Spanish Ministerio de Educacion programa FPU [AP2009-4556]
- Spanish Ministry of Economy and Competitiveness [SAF2013-42528-R]
- ISCIII-RETIC [RD12/0019/0031]
Heart failure still represents the leading cause of death worldwide. Novel strategies using stem cells and growth factors have been investigated for effective cardiac tissue regeneration and heart function recovery. However, some major challenges limit their translation to the clinic. Recently, biomaterials have emerged as a promising approach to improve delivery and viability of therapeutic cells and proteins for the regeneration of the damaged heart. In particular, hydrogels are considered one of the most promising vehicles. They can be administered through minimally invasive techniques while maintaining all the desirable characteristics of drug delivery systems. This review discusses recent advances made in the field of hydrogels for cardiac tissue regeneration in detail, focusing on the type of hydrogel (conventional, injectable, smart or nano-and micro-gel), the biomaterials used for its manufacture (natural, synthetic or hybrid) and the therapeutic agent encapsulated (stem cells or proteins). We expect that these novel hydrogel-based approaches will open up new possibilities in drug delivery and cell therapies. (C) 2016 Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据